Advertisement

South Dakota awaits approval to get 7K Johnson & Johnson COVID-19 doses weekly

Federal regulators will decide on whether to approve Johnson & Johnson’s vaccine within the coming days.
FILE - This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the Janssen...
FILE - This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States. Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday, Feb. 24, 2021, that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration’s scientists confirmed that overall, it's about 66% effective and also said J&J's shot, one that could help speed vaccinations by requiring just one dose instead of two, is safe to use.(AP)
Published: Feb. 25, 2021 at 12:44 PM CST
Email This Link
Share on Pinterest
Share on LinkedIn

RAPID CITY, S.D. (KOTA) - South Dakota is waiting on FDA approval to up its weekly vaccine allotment from the federal government.

Secretary of Health Kim Malsam-Rysdon said on Twitter that South Dakota could get 7,000 doses of Johnson & Johnson’s COVID-19 vaccine by next week if the FDA approves. This would boost the state’s allotment by 37% to 25,830 total vaccines a week.

The FDA issued a report Wednesday that found Johnson & Johnson’s vaccine is about 66% effective at preventing moderate to severe COVID-19. While this is lower than Pfizer’s or Moderna’s vaccine currently in use, Johnson & Johnson’s product is generally easier to store and is a single-dose vaccine--not two.

Federal regulators are expected to make a final decision on whether to approve Johnson & Johnson’s vaccine within the coming days.

Copyright 2021 KOTA. All rights reserved.